Ignite Creation Date:
2024-07-17 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06468852
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-06-04
Brief Title:
GDFT on the Postoperative Outcome in Head and Neck Cancer Surgery
Sponsor:
Beijing Tongren Hospital
Organization:
Beijing Tongren Hospital
Study Overview
Official Title:
Effect of Goal-Directed Fluid Therapy on the Postoperative Outcome in Head and Neck Cancer Surgery A Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate whether goal-directed fluid therapy GDFT can improve the postoperative recovery in patients undergoing head and neck cancer surgery It aims to answer is
Whether GDFT can reduce the occurrence of serious postoperative complications Researchers will compare GDFT protocol to a standard conventional fluid therapy in head and neck cancer surgery to see if GDFT strategy works to improve the postoperative recovery
Participants will
Receive GDFT protocol or a conventional fluid therapy during the surgery
Be continuously follow-up during hospitalization and after discharge to record the occurrence of postoperative complications
Whether GDFT can reduce the occurrence of serious postoperative complications Researchers will compare GDFT protocol to a standard conventional fluid therapy in head and neck cancer surgery to see if GDFT strategy works to improve the postoperative recovery
Participants will
Receive GDFT protocol or a conventional fluid therapy during the surgery
Be continuously follow-up during hospitalization and after discharge to record the occurrence of postoperative complications
Detailed Description:
Postoperative complications have become the main cause of prolonged hospitalization and reduced postoperative survival rate among surgical patients Goal-Directed Fluid Therapy GDFT has been reported to reduce the incidence of postoperative complications and mortality shorten the hospital stay and improve the outcome in major abdominal surgery patients However the benefit of the GDFT in patients undergoing head and neck surgery remains controversial The purpose of this study is to evaluate whether GDFT can reduce the occurrence of serious postoperative complications and shorten the postoperative hospital stay compared with a standard conventional fluid therapy in patients undergoing head and neck cancer surgery
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None